|
FOLFIRI Clinical Trials
13 actively recruiting trials across 9 locations
No change since May 2026
Also known as: 5-fluorouracil, Arm B, Folinic acid, 5-FU, Irinatecan, folinic acid (leucovorin)
Pipeline
Phase 1: 7Phase 2: 3Phase 3: 1Phase 1/2: 1Phase 2/3: 1
Top Sponsors
- Incyte Corporation2
- University of Alabama at Birmingham1
- Tizona Therapeutics, Inc1
- Oncolytics Biotech1
- Janssen Research & Development, LLC1
Indications
- Cancer13
- Lung Cancer3
- Unresectable Metastatic Colorectal Cancer2
- Solid Tumors2
- Colorectal Cancer2
Other2 trials
Birmingham, Alabama2 trials
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
UAB Comprehensive Cancer Center
Phase 1
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
University of Alabama at Birmingham
Phase 1
Tucson, Arizona2 trials
Phase 2/3
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Arizona Oncology Associates
Phase 1
Homewood, Alabama1 trial
Gilbert, Arizona1 trial
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Banner Health- MD Anderson Cancer Center
Phase 1/2
Phoenix, Arizona1 trial
Los Angeles, California1 trial
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
The Angeles Clinic and Research Institute
Phase 1
Aurora, Colorado1 trial
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
University of Colorado Denver Anschultz Medical Campus
Phase 1
Tampa, Florida1 trial
Boston, Massachusetts1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.